Michael Singer

MedicineEnvironmental ScienceBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation”.

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1631

N/A

0.542DataRank · unranked

36 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

Pharmacologic modulation of RNA splicing enhances anti-tumor immunity

Cell(2021)10.1016/j.cell.2021.05.038

N/A

0DataRank · unranked

284 citations

Emma De Neef, James D. Thomas, Erich Sabio, Benoı̂t Rousseau, Mathieu Gigoux +30 more

Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia

Cancer Cell(2022)10.1016/j.ccell.2022.12.002

N/A

0DataRank · unranked

78 citations

Jose Mario Bello Pineda, Won Jun Kim, Sisi Chen, Jessie Bourcier, Maximilian Stahl +22 more

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

(2023)10.1158/2159-8290.c.6549783

N/A

0DataRank · unranked

0 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition

Cancer Cell(2025)10.1016/j.ccell.2025.09.014

N/A

0DataRank · unranked

3 citations

Jean‐François Emile, T Fujino, Julien Haroche, Maxim I. Maron, Alexander M. Lewis +40 more